Stankovikj, Svetlana
Full Name
Stankovikj, Svetlana
Main Affiliation
Email
svetlana.stankovikj@medf.ukim.edu.mk
Loading...
2
0
5
0
false
Loading...
3
0
5
0
false
Type
Fulltext
Results 1-20 of 42 (Search time: 0.054 seconds).
| Preview | Title | Author(s) | Issue Date | Type | |
|---|---|---|---|---|---|
| 1 |  | Acquired hemophilia A-Part of our clinical experience | Smilevska, Tatjana; Stankovic, Svetlana ; Cevreska, Lidija | 2017 | Proceeding article |
| 2 |  | Acquired hemophilia A: Presentation of five cases | Svetlana Stankovikj ; Smilevska Tatjana; Dejanova Violeta; Sanja Trajkova ; Dukovski Dusko; Popova Marija | 2014 | Proceeding article |
| 3 |  | Acquired Inhibitors (Autoantibodies) to Factor VIII: A Case Report and Review of Literature | Vera Stankovic; Magdalena Ivanova; Borislav Manev; Svetlana Stankovic | 2010 | Proceeding article |
| 4 | Acute complications in multiple myeloma | Stankovikj, Svetlana ; Martinova, Kata | 2017 | Article | |
| 5 |  | Analysis from Final data from Multinational, Non-Interventional, Observational Emmos Study (NCTO1241396) in Patients with Multiple Myeloma (MM) in Real-World Clinical Practice | M. Mohty; E. Terpos; M-V. Mateos; A. Palumbo; S. Lejniece; M. Beksac; M.A. Bekadja; W. Legiec; M. Dimopoulos; Svetlana Stankovic ; M.S. Duran; V. De Stefano; A. Corso; Y. Kochkareva; E. Laane; C. Berthou; H-J. Salwender; Z. Masliak; V. Peceliunas; W. Willenbacher; J. Da Salva; V. Louw; D. Nemet; Z. Borbenyl; U. Abadi; R.S.Pe ersen; P. Cernelc; A. Potamianou; C. Couturier; R. Olie; C. Feys; F. Thoret-Bauchert; M. Boccadoro | 2015 | Proceeding article |
| 6 | Case report of a rare coagulation disorder-Acquired hemophilia A | Stankovikj, Svetlana ; Martinova, Kata ; Ivanovski Martin; Karanfilski, Oliver ; Sotirova, Tatjana ; Milovska Dijana; Stojanoski, Zlate ; Cevreska Lidija | 2016 | Article | |
| 7 |  | CD-20 negative relapse following Rituximab therapy in patient with low-grade NHL-Case report | Stankovikj, Svetlana | 2011 | Proceeding article |
| 8 | Chelation therapy in thalassemia major: Why and when | Martinova, Kata ; Kocheva, Svetlana ; Conevska-Jovanova Biljana; Acevska-Jovanovska Aleksandra; Stankovic, Svetlana | 2015 | Article | |
| 9 | Clinical significance of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemia | Jovanovska Aleksandra; Kata Martinova ; Svetlana Kocheva ; Trajkova-Antevska Zorica; Conevska-Jovanova Biljana; Irina Panovska-Stavridis ; Svetlana Stankovikj ; Sanja Trajkova ; Aleksandar Dimovski | Sep-2019 | Article | |
| 10 | Current status in management of patients with chronic lymphocytic leukemia (CLL) in Republic of Macedonia | Pavkovic, Marica ; Sonja Genadieva Stavric ; Gazmend Amzai ; Tatjana Sotirova ; Lidija Cevreska; Svetlana Stankovic ; Aleksandar Stojanovic | Jan-2016 | Article | |
| 11 | Efficasy, safety and pharmacokinetic profiles of a plasma-derived VWF/FVIII concentrate (Voncento) in subjects with hemophilia A (SWIFT-HA study) | Aleksander Skotnicki; Toshko J.Lissitckov; Vasily Mamonov; Evgeny Buevich; Kazimerz Kuliczkowski; Stefcho Goranov; Janusz Kloczko; Anna Klukowska; Svetlana Stankovic ; Liana Gercheva; Tatiana Chernova; Andrzej Hellmann; Anna Dmoszynska; Krystyana Zawilska; Alex VeldmanChristine Joch; Wilfried Seifert | 2016 | Article | |
| 12 | Efficasy, safety, and pharmacokinetics results of a phase II, double-blinded, randomized, cross-over study with Biostate in subjects with hemophilia A (the SWIFT-HA Study) | A.Skotnicki; Toshko J Lissitchkov; Vasily Mamonov; Evgeny Buevich; Kazimierz Kuliczkowski; Stefcho Goranov; Janusz Kłoczko; Anna Klukowska; Svetlana Stankovic ; Liana Gercheva; Tatiana Chernova; Andrzej Hellmann; Anna Dmoszyńska; Krystyna Zawilska; Alex Veldman; Christine Joch; Wilfried Seifert | 2012 | Proceeding article | |
| 13 |  | Efficasy, safety, and pharmacokinetics results of a phase II/III, multicentre, double-blinded, randomized, cross-over study with a plasma-derived von Wilebrand Factor (WVF)/factor VIII (FVIII) concentrate (Voncento) in subjects with hemophilia A (the SWIFT-HA Study) | A. Klukowska; A. Skotnicki; T. Lissitchkov; V. Mamonov; E. Buevich; K. Kuliczkowski; S. Goranov; J. Kolczko; S. Stankovic ; W. Seifert | 2014 | Proceeding article |
| 14 |  | Evaluation of reproducibility of prognostic index and nomogram in prognosis, and therapeutically approach of patients with Chronic Lymphocytic Leukemia-single centre experience | Trajkova, Sanja ; Cevreska Lidija; Ivanovski Martin; Dukovski Dusko; Simjanovska-Popova Marija; Stankovik Svetlana ; Panovska Stavridis Irina | 2014 | Article |
| 15 |  | Frequency of multidrug resistant bacterial isolates in stem cell transplant recipients-single center experience | Stojanoski Z ; Georgievski B ; Genadieva Stavrik S ; Pivkova A ; Cevreska L; Cadievski L; Kocoski B; Miloska D; Panovska Stavridis I ; Trajkova S ; Ivanovski M; Karanfilski O ; Stojanovik A; Stankovic S | 2017 | Proceeding article |
| 16 |  | Frontline induction therapy for multiple myeloma (MM) in real-world clinical practice: Third interim analysis of the multinational, observational EMMOS study (NCT01241396) | Mohamed Mohty; Evangelos Terpos; Maria-Victoria Mateos; Antonio Palumbo; Wojciech Legiec; Meral Beksac; Edward Laane; Mohamed Amine Bekadja; Damir Nemet; Valdas Peceliunas; Michele Cavo; Philipe Moreau; Tomas Masszi; Peter Cernelc; Jaime Perez de Oteyza; Hans Salwender; Uri Abadi; Meletios Dimopoulos; Svetlana Stankovic ; GalinaNikolaevna Salogub; Wolfgang Willenbacher; Niels Abildgaard; Karen Gunther; Joao Silva; Sandra Lejniece; Irina Dyagil; Anna Potamianon; Catherine Couturier; Robert Olie; Caroline Feys; Florence Thort-Bander; Mario Boccadoro | 2015 | Proceeding article |
| 17 |  | Frontline therapy for multiple myeloma in real-world clinical practice: Results from the third interim analysis of the multinational, non-interventional, observational EMMOS study | Mohamed Mohty; Evangelos Terpos; Maria-Victoria Mateos; Antonio Palumbo; Sandra Lejniece; Meral Beksac; Mohamed Amine Bekadja; Wojciech Legiec; Meletios Dimopoulos; Svetlana Stankovic ; Maria Soledad Duran; Valerio De Stefano; Yulia Kochareva; Edward Laane; Christian Berthou; Hans Salwender; Zvenislava Masliak; Valdas Peceliunas; Wolfgang Willenbacher; Joao Silva; Vernon Louw; Damir Nemet; Zita Borbenyl; Uri Abadi; Robert Schou Pedersen; Peter Cernelc; Anna Potamianon; Catherine Couturier; Robert Olie; Caroline Feys; Florence Thort-Bander; Mario Boccadoro | 2015 | Proceeding article |
| 18 |  | Greater efficacy and less product consumption in early treatment of iliopsoas hemorrhage in patient with hemophilia and high titer inhibitor | Stankovic, S. | May-2013 | Proceeding article |
| 19 |  | Idiopathic pulmonary hemosiderosis; a retrospective study from a pediatric hematology-oncology center | K. Martinova ; S. Stankovic ; O. Muratovska; S. Glamocanin | 2011 | Proceeding article |
| 20 |  | Immunophenotype distinction between acute promyelocytic leukemia and HLA-DR-CD34 negative acute myeloid leulemia: single center experience | D. Dukovski; L. Cevreska; S. Trajkova ; M. Ivanovski; M. Popova-Simjanovska; S. Stankovik ; I. Panovska Stavridis | 2013 | Proceeding article |